Investigations on Congenital and
Induced Osteopetrosis
DONALD G. WALKER

Department of Anatomy, The Johns Hopkins University School of
Medicine, Baltimore, Maryland 21205

Osteopetrosis, or marble bone
disease, is a disturbance of skeletal
development in which the rate of
bone resorption fails to keep pace
with the rate of bone formation.
Bone matrix accumulates excessively throughout the skeletal system, causing damage to neighboring tissues-particularly the dental,
hematopoietic and nervous tissues.
The line of investigation on
osteopetrosis which has led to the
current point of view that the thyroid gland represents the primary
site of the disturbance was initiated
soon after an experimental animal
became available. In 1935 Hans
Grlineberg described a mutant of
the house mouse, named the greylethal , whose skele tal system
showed manifestations of osteopetrosis which closely resembled
those in man originally described
by Albers-Schonberg in 1904.
Barnicot (1948), working at University College, was the first to
show that osteopetrosis is an endocrine disorder. His most interesting
work involved the reciprocal transplantation of parathyroid tissue and
bone. In one experiment he took
from a grey-lethal mouse a piece of
calvarial bone and a parathyroid
body, attached the gland to the
surface of the bone, and implanted
the graft intracerebrally in a normal
sibling. A few days later, when the
graft was removed for examination,
the calvarial bone was found to
have been perforated in the region
underlying the parathyroid gland.
When the grey-lethal mouse was
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roid body and bone obtained from
a normal littermate, little or no evidence of bone erosion was demonstrable at the end of the culture
period.
In another experiment (Barnicot,
1941) , ribs from a grey-lethal
mouse were transplanted into a
normal littermate. When examined histologically two weeks later,
the rib grafts appeared normal.
In the reciprocal transplantation,
in which a rib from a normal
mouse was cultured subcutaneously
in a grey-lethal littermate, the graft
underwent osteopetrotic changes.
From these results it was evident
that the failure of bone remodelling
in the osteopetrotic mouse was not
explicable on the basis of incompetence on the part of either osteoclasts or the chief cells of the parathyroid gland. In an effort to
promote the resorption of the excess bone, Barnicot ( 1945) discovered that the grey-lethal mouse
suffered no ill effects from repeated
injections of parathyroid extract
(PTE) at a dose level that was
toxic enough to kill the normal
siblings after only one exposure.
Thus, Barnicot terminated his study
of the grey-lethal mouse by suggesting that osteopetrosis is a form
of hypoparathyroidism which cannot be cured by parathormone
therapy alone.
There are two reasons why the
"hypoparathyroid hypothesis" is
not tenable. It has long been known
that normal mice which have been
thyroparathyroidectomized at birth
do not develop osteopetrosis. Fur-

thermore, the fact that bone erosion failed to occur, even when the
parathyroid body was in direct contact with the calvarial bone, rules
out the possibility that a parathormone-destroying tissue intervenes
between the gland and its target.
In seeking additional information
as a basis for an alternative to
Barnicot's explanation, I first devoted my efforts to measuring the
plasma calcium concentration in
untreated animals of both sexes at
various ages. All of the grey-lethals
examined, including the younger
well-nourished group, were found
to be hypocalcemic, with a total
plasma calcium averaging 20 % below the mean value of plasma calcium obtained from the normal
littermates. In response to a single
injection of PTE at a dosage of
5 units/ gm of body weight, the
plasma calcium level of normal
mice one to four weeks of age
increased by 100% in 18 hours
and 200 % in 36 hours. Grey-lethal
mice given the same dosage of
PTE showed a maximum elevation
of plasma calcium concentration of
only 25 % , reached within 18
hours. By 36 hours the plasma calcium fell to a tetanic threshold
level. In response to injections of
PTE administered at intervals of
12 hours for as long as eight days,
the grey-lethal mouse never became hypercalcemic, whereas the
normal littermates invariably died
by the second or third day with
extreme hypercalcemia and nephrocalcinosis.
In an effort to locate the basis
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for the great resistance to parathyroid hormone observed in the greylethal, a thorough cytological and
histochemical assessment of osteoclasts was conducted. Bone samples
obtained from grey-lethals between
12 and 24 hours after the administration of parathormone showed
widespread or intense signs of osteoclastic activity, including an exceptionally high level of collagenase (Walker, l 966a). However, in
the untreated mice and at all time
points later than 24 hours in the
parathormone-treated animals, osteolytic activity was subnormal,
whereas the signs of increased osteoblastic activity were most impressive . The endosteum was hyperplastic, containing several layers
of osteoprogenitor cells as well as
a prominent layer of large osteoblasts; adjacent to the endosteum
was a thick seam of osteoid. The
hyperplastic endosteum was distributed over most of the trabecular
surface in the grey-lethal bones. In
order to place the osteogenic evaluation on a quantitative basis, I
employed tritiated proline incorporation studies. Tritiated proline
was administered intraperitoneally
at a dosage of 4µ,c to 8µ,c per
gm of body weight, and the animal
was sacrificed six hours later.
Samples of calvarial and tibial bone
were pulverized, extracted in ether,
suspended in scintillation fluid and
counted by means of a well-type
automated scintillation counter. The
counts obtained from the untreated
animals indicated that the greylethal incorporated 50 % more of
the 3H-proline into bone matrix
than the normal control. Parathyroid hormone was found to depress
incorporation in the normal by
about 50 % but in the grey-lethal
by only about 15 % (Walker,
1966b).
According to our interpretation
of the results of the evaluation of
osteolytic and osteogenic activities
in the osteopetrotic mouse, the imbalance leading to the excessive accumulation of bone is more likely
to be due to increased osteoblastic
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activity than to decreased osteoclastic activity. In attempting to
locate an abnormally enlarged
source of an osteoblastic-stimulating factor, the pituitary and thyroid
glands were surveyed thoroughly
by means of light and electron microscopy. No evidence of increased
somatotroph or follicle cell activities was disclosed ; however, a
parafollicular cell hyperplasia was
discovered in the parathormonetreated grey-lethals. In electron micrographs the parafollicular cell
differs from the follicle cell in
several respects. It is of a larger
size, has a shape that is oval instead
of polygonal, and occupies a more
peripheral (parafollicular) position, resting against the basement ·
membrane of the follicle but never
bordering directly on the colloid.
Unlike all other epithelial cells, the
parafollicular cells are devoid of
intercellular attachment devices,
such as desmosomes, light junctions, and interlocking processes.
The most distinctive feature of the
parafollicular cells is the abundance
of cytoplasmic secretory vesicles.
These vesicles are about 0.2µ, in
diameter and appear to be empty
but may contain thyrocalcitonin,
a substance of homogeneous appearance and low electron opacity.
Since the parafollicular cell has
been shown to be the source of
thyrocalcitonin, the presence of a
parafollicular cell hyperplasia may
represent an excessive capacity to
produce thyrocalcitonin. Chronic
hypercalcitoninemia would be associated with sustained hypocalcemia, hypophosphatemia, and a
retardation of bone resorption. All
of these signs are characteristic of
osteopetrosis as manifested in the
grey-lethal mouse. The increased
rate of bone formation observed in
the grey-lethal might indicate that
thyrocalcitonin has a dual action on
bone-inhibiting osteolytic activity,
yet stimulating osteogenic activity
-a combination of effects diametrically opposed to the effects of
parathormone.
In addition to the grey-lethal,

three other mutants with osteopetrosis have recently been studied.
The implication of the findings obtained in microphthalmic and osteosclerotic mice is essentially the
same as the implication of the findings obtained from the grey-lethal
(S. C. Marks and D. G. Walker,
unpublished data) .
Rabbits with hereditary osteopetrosis as well as the mice with congenital osteopetrosis are hypocalcemic throughout life. They fail
to develop hypercalcemia even
when placed on an intensive parathormone regimen. However, the
abnormal tolerance · to parathormone in the rabbit does not seem
to be related to parafollicular cell
activity, as it was in osteopetrotic
mice. The parafollicular cell population is not elevated in the rabbits,
and, even after thyroidectomy or
thyroparathyroidectomy, the osteopetrotic rabbits are refractory to
the influence of parathormone. Furthermore, the rabbit mutants never
show increased osteogenic activity;
in fact, according to tritiated proline incorporating studies carried
out at various ages from birth to
one month of age, their capacity to
make bone matrix is only about
half that of the normal littermates.
Osteopetrotic rabbit bones show reduced numbers of osteoblasts, osteoclasts of abnormal appearance
and an abundance of mesenchyme
throughout
the intertrabecular
spaces (D. G. Walker and R . R.
Fox, unpublished data) .
On the basis of the fragmentary
data available at present, the primary defect in hereditary osteopetrosis of the rabbit appears to be
located in osseous tissue rather
than in the endocrine system.
Recently, osteopetrosis has been
induced in normal mice (S. C.
Marks, unpublished data), rabbits
and rats (D. G . Walker and M.A.
Shepp, unpublished data) by means
of daily injections of PTE at the
moderately low dose level of 0.5
units/ gm of l:\ody weight. Throughout the two-week or longer PTE
regimen initiated at birth, the med-
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ullary cavities of the long bones
failed to enlarge, and the cancellous bone of the epiphyses and metaphyses became increasingly dense,
gradually approaching compact
bone in appearance. The experimentally osteopetrotic animals, like
the congenitally osteopetrotic mice,
showed increased extent of osteoblastic activity in autoradiographic
studies and elevated levels of tritiated proline incorporation into bone
matrix as determined by counting
of radioactivity. In general, the
counts indicated that the experimental animals incorporated two
to three times as much of the administered label as did their normal
littermate controls. In addition,
parafollicular cell hyperplasia was
shown to exist in all of the animals
with induced osteopetrosis. The
parafollicular cell population in the
experimental animals was increased
about eightfold over that of the
controls.
The explanation for the mechanism which induced osteopetrosis in
normal mice was as follows. The
daily injection of PTE caused a
transient hypercalcemia. This, in
turn, stimulated the secretory and
proliferative activities of the parafollicul ar cells, leading to an overproduction of thyrocalcitonin. The
explanation received additional support from the finding that osteopetrosis could not be induced in
mice that had been completely
thyroidectomized. In those instances
where the thyroidectomy was not
complete, the degree of osteopetrosis induced by the parathormone
regimen correlated directly with
the number of parafollicular cells
counted in the remnant of thyroid
gland (S. C. Marks and D . G.
Walker, unpublished data).
From these investigations on
hereditary and induced osteopetrosis has emerged the theory that
the parafollicular cell is the source
of a potent osteoblast-stimulating
factor which may be an entity distinct from thyrocalcitonin. According to general consensus, thyrocalcitonin has but one action, namely,

inhibiting bone resorption. Therefore, at the present time we are investigating other possible sources
for the osteoblast-stimulating influence. In order to determine whether
or not the growth-promoting effect
was mediated by the pituitary gland,
rats hypophysectomized at two
weeks of age were injected with
either growth hormone or PTE or a
combination of the two hormones
for a period of three weeks. As
compared with the untreated hypophysectomized controls, hormoneinjected hypophysectomized rats
showed approximately a tenfold increase in the number of parafollicular cells of the thyroid gland
and a threefold to fivefold increase
in the bone label-incorporating capacity. The excessive accumulation
of bone matrix was observed only
in those animals receiving PTE,
but the .osteopetrotic trend developed more rapidly in animals receiving growth hormone in addition to PTE. The disturbance of
calcium homeostasis that leads to
the excessive accumulation of bone
matrix occurs not only when the
endogenous source of parathormone is inhibited, but also when
thyrocalcitonin production is increased. This dual effect is created
by the administration of PTE at a
low dose level. However, administration of growth hormone indirectly stimulates the activities of
the chief cell of the parathyroid
gland as well as the parafollicular
cell of the thyroid and, thus, calcium homeostasis is not disturbed .
The fact that growth hormone acts
synergistically with PTE in producing osteopetrosis can be explained simply by the fact that
growth hormone stimulates chondrogenesis, and the more rapid the
rate of cartilage production by the
epiphyseal plate, the more rapid
the bone accumulation under conditions where bone resorption has
been inhibited.
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